Back
Terns Pharmaceuticals Stock Predictions

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
35
TERN
Terns Pharmaceuticals
Last Price:
$3.02
Seasonality Move:
39.06%
7 Day Trial
ALL ACCESS PASS
$
7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioTerns Pharmaceuticals Stock Forecast
-
Is Terns Pharmaceuticals Stock Undervalued?The current Terns Pharmaceuticals [TERN] share price is $3.02. The Score for TERN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
TERN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Terns Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Terns Pharmaceuticals Stock Rating
Data Unavailable
Terns Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ternspharma.com
52-Week Data
52-Week High:
11.40
52-Week Low:
1.87
Prediction Charts
Market Cap:
263.8M
Price in USD:
3.02
Volume:
544.6K
Beta:
-0.16
Technical Analysis
SMA50:
2.86
SMA100:
3.61
SMA200:
5.50
52-Wk Change:
-48.46%
Stock Predictions
-
Is Terns Pharmaceuticals stock public?Yes, Terns Pharmaceuticals is a publicly traded company.
-
What is the Terns Pharmaceuticals stock quote today?The Terns Pharmaceuticals stock price is 3.02 USD today.
-
How to buy Terns Pharmaceuticals stock online?You can buy Terns Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-6 | 3.23 | 3.01 | 3.29 | 2.96 |
May-7 | 3.02 | 3.03 | 3.15 | 2.97 |
May-8 | 3.03 | 3.00 | 3.11 | 2.93 |
May-9 | 3.04 | 3.04 | 3.40 | 3.02 |
May-12 | 3.13 | 3.02 | 3.27 | 2.96 |
May-13 | 3.02 | 2.90 | 3.05 | 2.90 |
May-14 | 2.89 | 2.78 | 2.98 | 2.73 |
May-15 | 2.74 | 2.79 | 2.79 | 2.66 |
May-16 | 2.79 | 2.88 | 2.94 | 2.75 |
May-19 | 2.82 | 3.15 | 3.16 | 2.82 |
May-20 | 3.15 | 3.15 | 3.22 | 3.03 |
May-21 | 3.08 | 3.00 | 3.14 | 2.94 |
May-22 | 2.98 | 2.94 | 3.03 | 2.92 |
May-23 | 2.84 | 3.02 | 3.04 | 2.84 |
Terns Pharmaceuticals Earnings
Data Unavailable
Terns Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.02 per share.
* Terns Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.